CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 16.22
  • -0.27-1.64%
Market Closed Dec 13 15:00 CST
18.47BMarket Cap21.71P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DaShenLin Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.36B
6.39B
+21.55M
Beat Est.
+11.04%
+11.42%
+0.34%
EPS
0.24
0.18
-0.06
Miss Est.
+7.82%
-21.74%
-24.11%
Analyst Rating
Strong Buy

Dec 14, 2024

DaShenLin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.159B--
--2024/Q4-- / 7.282B--
Oct 31, 20242024/Q36.386B / 6.364B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.159B--
--2024/Q4-- / 7.282B--
Oct 31, 20242024/Q36.386B / 6.364B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--

Unlock Free Earnings Estimates

DaShenLin Pharmaceutical Group Earnings Reports

  • Dashanlin: Dashanlin Pharmaceutical Group Co., Ltd. Third Quarter Report 2024

    Oct 30 12:00 ET

  • Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the main operating data for the third quarter of 2024

    Oct 30 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024

    Oct 30 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report

    Aug 30 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    KAYO MOTOR
    834058
    38.58 +29.99%
    Zhejiang Zoenn Design
    300901
    14.86 +20.03%
    Zhejiang Meorient Commerce & Exhibition Inc.
    300795
    22.36 +20.02%
    Fujian Zitian Media Technology
    300280
    22.18 +20.02%
    Zhejiang Prulde Electric Appliance
    301353
    36.46 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 14, 2024

    Strong Buy

    • Strong Buy

      76.19%

    • Buy

      23.81%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday-1.84%
    Pharmaceutical E-commerce
    Pharmaceutical E-commerce
    Intraday-1.88%